CN108653434A - 一种治疗脾虚痰湿型多囊卵巢综合征的药物组合物 - Google Patents
一种治疗脾虚痰湿型多囊卵巢综合征的药物组合物 Download PDFInfo
- Publication number
- CN108653434A CN108653434A CN201810754444.2A CN201810754444A CN108653434A CN 108653434 A CN108653434 A CN 108653434A CN 201810754444 A CN201810754444 A CN 201810754444A CN 108653434 A CN108653434 A CN 108653434A
- Authority
- CN
- China
- Prior art keywords
- leventhal syndrome
- pharmaceutical composition
- radix
- stein
- sputum type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000952 spleen Anatomy 0.000 title claims abstract description 54
- 201000010065 polycystic ovary syndrome Diseases 0.000 title claims abstract description 43
- 206010036049 Polycystic ovaries Diseases 0.000 title claims abstract description 41
- 206010036790 Productive cough Diseases 0.000 title claims abstract description 41
- 208000024794 sputum Diseases 0.000 title claims abstract description 40
- 210000003802 sputum Anatomy 0.000 title claims abstract description 40
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 44
- 235000019441 ethanol Nutrition 0.000 claims abstract description 23
- 239000009636 Huang Qi Substances 0.000 claims abstract description 19
- 206010062717 Increased upper airway secretion Diseases 0.000 claims abstract description 19
- 208000026435 phlegm Diseases 0.000 claims abstract description 19
- 230000007812 deficiency Effects 0.000 claims abstract description 16
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000004140 cleaning Methods 0.000 claims abstract description 4
- 241001619444 Wolfiporia cocos Species 0.000 claims abstract 4
- 239000000243 solution Substances 0.000 claims description 25
- 239000003814 drug Substances 0.000 claims description 24
- 239000012528 membrane Substances 0.000 claims description 15
- 238000000108 ultra-filtration Methods 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 239000003960 organic solvent Substances 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 7
- 229910052770 Uranium Inorganic materials 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 6
- 239000000469 ethanolic extract Substances 0.000 claims description 6
- 229920002521 macromolecule Polymers 0.000 claims description 6
- JFALSRSLKYAFGM-UHFFFAOYSA-N uranium(0) Chemical compound [U] JFALSRSLKYAFGM-UHFFFAOYSA-N 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 4
- 230000000857 drug effect Effects 0.000 claims description 3
- 239000012634 fragment Substances 0.000 claims description 3
- 238000013327 media filtration Methods 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 239000013049 sediment Substances 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims 4
- 238000009505 enteric coating Methods 0.000 claims 1
- 239000002702 enteric coating Substances 0.000 claims 1
- 239000007888 film coating Substances 0.000 claims 1
- 238000009501 film coating Methods 0.000 claims 1
- 208000037093 Menstruation Disturbances Diseases 0.000 abstract description 8
- 206010027339 Menstruation irregular Diseases 0.000 abstract description 8
- 208000024891 symptom Diseases 0.000 abstract description 7
- 229940079593 drug Drugs 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 11
- 206010011224 Cough Diseases 0.000 description 10
- 244000197580 Poria cocos Species 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 6
- 241000756943 Codonopsis Species 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 208000025865 Ulcer Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 231100000397 ulcer Toxicity 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 244000303040 Glycyrrhiza glabra Species 0.000 description 4
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 4
- 235000017443 Hedysarum boreale Nutrition 0.000 description 4
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 4
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000002124 endocrine Effects 0.000 description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical group O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 241000205585 Aquilegia canadensis Species 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 208000006083 Hypokinesia Diseases 0.000 description 2
- 229930194248 Licoflavone Natural products 0.000 description 2
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- GKIRPKYJQBWNGO-OCEACIFDSA-N clomifene Chemical compound C1=CC(OCCN(CC)CC)=CC=C1C(\C=1C=CC=CC=1)=C(\Cl)C1=CC=CC=C1 GKIRPKYJQBWNGO-OCEACIFDSA-N 0.000 description 2
- 229960003608 clomifene Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000002662 enteric coated tablet Substances 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 239000007941 film coated tablet Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 201000010066 hyperandrogenism Diseases 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 208000021267 infertility disease Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229940100688 oral solution Drugs 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 230000016087 ovulation Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 235000021251 pulses Nutrition 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000132092 Aster Species 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000522254 Cassia Species 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 241000283966 Pholidota <mammal> Species 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 240000004980 Rheum officinale Species 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241001601725 Sthenias Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 240000006688 Telosma cordata Species 0.000 description 1
- 235000017352 Telosma cordata Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 240000000377 Tussilago farfara Species 0.000 description 1
- 235000004869 Tussilago farfara Nutrition 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 208000036654 deficiency anemia Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- -1 oral solution Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 238000004634 pharmacological analysis method Methods 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 201000010727 rectal prolapse Diseases 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000009571 yupingfeng Substances 0.000 description 1
- 239000008945 zhigancao decoction Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于脾虚痰湿型多囊卵巢综合征治疗技术领域,公开了一种治疗脾虚痰湿型多囊卵巢综合征的药物组合物。由黄芪2g、丹参3g、茯苓2g、陈皮2g、苍术4g、当归3g、川芎1g和甘草1.5g组成。在制作时,取黄芪2g、丹参3g、茯苓2g、陈皮2g、苍术4g、当归3g、川芎1g和甘草1.5g,洗净后,加水进行煎煮,煎煮过后,收集煎煮出的提取液;随后重复煎煮,进行多次提纯,全部材料提纯完毕后,将最后的提取液进行混合,随后加入乙醇进行保存。本发明分别针对多囊卵巢综合征的脾虚湿痰、月经不调症状进行中药调理,全方位的对病人的症状进行治疗,很好的解决了脾虚痰湿型多囊卵巢综合征的主要病症。
Description
技术领域
本发明属于脾虚痰湿型多囊卵巢综合征治疗技术领域,尤其涉及一种治疗脾虚痰湿型多囊卵巢综合征的药物组合物。
背景技术
多囊卵巢综合征是一种育龄期女性常见的病因多样性、临床表现多态性的内分泌代谢紊乱性疾病,以月经不调或者闭经、高雄激素血症以及卵巢呈多囊样改变为特征。临床中脾虚痰湿型多囊卵巢综合征较为多见,其症状表现为月经不调、形体肥胖、闭经、不孕,兼见脘腹胀满;胸闷呕恶;面色晃白;带下量多;舌淡胖,苔白腻,脉沉细或沉滑等脾虚痰湿的症状。多囊卵巢综合征在青春期多表现为月经不调、肥胖、多毛、痤疮,在育龄期主要是为不孕和代谢综合征,在围绝经期多为心血管疾病并发症等,该病困扰着患者的一生,并伴随着严重的精神心理问题。多囊卵巢综合征是国内外研究的热点和难点,西医目前多采用对症治疗,针对不孕采用克罗米芬作为一线促排卵药物;针对胰岛素抵抗采用胰岛素曾敏剂治疗;针对高雄激素血症采用降雄治疗。但最新研究发现部分患者存在克罗米芬抵抗或者不敏感现象,患者用药后不能达到促排卵的效果,且西药副作用大。介于这些,本发明提出一种治疗脾虚痰湿型多囊卵巢综合征的药物组合物,从“整体观”对患者进行调整。
综上所述,现有技术存在的问题是:西药治疗只是对症治疗,无法从整体对患者的症状进行全面干预,且西药毒副作用大,用药后受孕,母儿的远期安全性令人堪忧。
解决上述技术问题的难度和意义:
发明内容
针对现有技术存在的问题,本发明提供了一种治疗脾虚痰湿型多囊卵巢综合征的药物组合物。
本发明是这样实现的,一种治疗脾虚痰湿型多囊卵巢综合征的药物组合物,所述治疗脾虚痰湿型多囊卵巢综合征的药物组合物由黄芪2g、丹参3g、茯苓2g、陈皮2g、苍术4g、当归3g、川芎1g和甘草1.5g组成。
本发明的另一目的在于提供一种所述治疗脾虚痰湿型多囊卵巢综合征的药物组合物的制备方法,所述治疗脾虚痰湿型多囊卵巢综合征的药物组合物的制备方法包括以下步骤:
步骤一,在制作时,取黄芪2g、丹参3g、茯苓2g、陈皮2g、苍术4g、当归3g、川芎1g和甘草1.5g,洗净后,加水进行煎煮,煎煮过后,收集煎煮出的提取液;
步骤二,随后重复煎煮,进行多次提纯,全部材料提纯完毕后,将最后的提取液进行混合,随后加入乙醇进行保存。
进一步,所述步骤一中将提取液通过过滤精度为0.08μm介质过滤,以去除提取液III中的粒径大于0.08μm的大分子物质,再将滤出液通过超滤过滤来滤出提取液中无药效的分子量大于5000~10000道尔顿的有机大分子物质,得到纯度高的中药有效成份提取液;超滤过滤,所采用的超滤膜随处理中药不同选择切割分子量为5000~10000道尔顿;所述超滤过滤,可以根据所提取中药有效成份的分子量选取不同切割分子量的超滤膜;
进一步,所述步骤一中中药有效成份进一步提纯、浓缩:将提取液通过纳滤膜以去除提取液IV中的有机溶剂水溶液的有机溶剂;所述的铀滤过滤,所采用的铀滤膜随有机溶剂水溶液中有机溶剂分子量的不同选择切割分子量为200~500道尔顿的纳滤膜。
进一步,所述步骤一中将黄芪实体破啐成0.5~1厘米大碎块,投入不锈钢的提取锅中,加黄芪干重8倍的95%食用乙醇,78℃回流1小时,放出醇提液;残渣仍留在锅中,再加8倍重量的75%食用乙醇,78℃回流1小时,放出乙醇提取液;残渣仍留在锅中,再加8倍量50%食用乙醇,78℃回流1小时,放出乙醇提取液;将3次醇提液合并,在贮液槽中静置10小时,取出上层清液,弃去底部沉淀物;上清液回收乙醇。
本发明的另一目的在于提供一种由所述治疗脾虚痰湿型多囊卵巢综合征的药物组合物制备的片剂。
本发明的另一目的在于提供一种由所述治疗脾虚痰湿型多囊卵巢综合征的药物组合物制备的薄膜衣片剂。
本发明的另一目的在于提供一种由所述治疗脾虚痰湿型多囊卵巢综合征的药物组合物制备的肠溶衣片剂。
本发明的另一目的在于提供一种由所述治疗脾虚痰湿型多囊卵巢综合征的药物组合物制备的胶囊剂。
本发明的另一目的在于提供一种由所述治疗脾虚痰湿型多囊卵巢综合征的药物组合物制备的口服液。
本发明的优点及积极效果为:此治疗脾虚痰湿型多囊卵巢综合征的药物组合物的成分分为三大类,分别针对脾虚,湿痰以及月经不调症状进行健脾利湿、调理冲任,针对多囊卵巢综合征的常见症状对病人进行整体治疗,很好的解决了脾虚痰湿型多囊卵巢综合征的主要病症。此治疗药物组合物成分明确,配伍合理,并且成分均为中药,以健脾为主,兼以利湿化痰,最终达到调理冲任,月经节律有序,脾健水湿得以运化,从而对肥胖等代谢问题进行很好的调理,最大程度的为患者解决了内分泌代谢问题。
本发明的补肾健脾、化痰利湿成分:黄芪、丹参、茯苓、陈皮、苍术;调整月经、调理冲任成分:当归、川芎、甘草;方中黄芪、丹参补肾健脾理气,茯苓、陈皮、苍术化痰燥湿健脾,当归、川芎活血通经,调理冲任,甘草调和诸药。本病脾虚痰湿型PCOS虽为痰湿为患,其本证属虚实,其本多由脾虚血亏,久则累及肾阳,或为肝气郁结而成,脾之运化无力,湿聚成痰。其治法应以“虚则补之,实则泻之”为原则,采用通补之法,配合使用,权衡则重。本发明由苍附导痰丸(《叶天士女科全书》化裁而来。
附图说明
图1是本发明实施例提供的治疗脾虚痰湿型多囊卵巢综合征的药物组合物的制备方法流程图。
具体实施方式
为能进一步了解本发明的发明内容、特点及功效,兹例举以下实施例,并配合附图1详细说明如下。
下面结合附图对本发明的结构作详细的描述。
本发明实施例提供的治疗脾虚痰湿型多囊卵巢综合征的药物组合物由黄芪2g、丹参3g、茯苓2g、陈皮2g、苍术4g、当归3g、川芎1g和甘草1.5g组成。
如图1所示,本发明实施例提供的治疗脾虚痰湿型多囊卵巢综合征的药物组合物的制备方法包括以下步骤:
S101:在制作时,取黄芪2g、丹参3g、茯苓2g、陈皮2g、苍术4g、当归3g、川芎1g和甘草1.5g,洗净后,加水进行煎煮,煎煮过后,收集煎煮出的提取液;
S102:随后重复煎煮,进行多次提纯,全部材料提纯完毕后,将最后的提取液进行混合,随后加入乙醇进行保存。
在步骤S101中将提取液通过过滤精度为0.08μm介质过滤,以去除提取液III中的粒径大于0.08μm的大分子物质,再将滤出液通过超滤过滤来滤出提取液中无药效的分子量大于5000~10000道尔顿的有机大分子物质,得到纯度高的中药有效成份提取液;超滤过滤,所采用的超滤膜随处理中药不同选择切割分子量为5000~10000道尔顿;所述的超滤过滤,可以根据所提取中药有效成份的分子量选取不同切割分子量的超滤膜;
中药有效成份进一步提纯、浓缩:将提取液通过纳滤膜以去除提取液IV中的有机溶剂水溶液的有机溶剂,以达到提纯、浓缩的目的;所述的铀滤过滤,所采用的铀滤膜随有机溶剂水溶液中有机溶剂分子量的不同选择切割分子量为200~500道尔顿的纳滤膜。
将黄芪实体破啐成0.5~1厘米大碎块,投入不锈钢的提取锅中,加黄芪干重8倍的95%食用乙醇,78℃回流1小时,放出醇提液。残渣仍留在锅中,再加8倍重量的75%食用乙醇,78℃回流1小时,放出乙醇提取液。残渣仍留在锅中,再加8倍量50%食用乙醇,78℃回流1小时,放出乙醇提取液。将3次醇提液合并,在贮液槽中静置10小时,取出上层清液,弃去底部沉淀物;上清液回收乙醇。去乙醇后的浓缩物可制成町剂,也可烘干或喷雾干燥后做成胶囊等制剂。
本发明实施例提供的治疗脾虚痰湿型多囊卵巢综合征的药物组合物可以是片剂、薄膜衣片剂、肠溶衣片剂、胶囊剂、硬胶囊剂、软胶囊剂、口服液、颗粒剂、蜜丸剂、散剂、丹剂、溶液剂等。
下面结合药理性分析对本发明的应用原理做进一步的描述。
黄芪,表虚自汗:多用于体虚表弱所致的自汗。如表气不固,而汗出,用黄芪配白术、防风治之,久服必效。方如玉屏风散;也可配浮小麦、麻黄根等。阴虚盗汗:可与生地、麦冬等滋阴药同用。急性肾炎水肿:用于阳气不足所致的虚性水肿,并常与防已、茯苓、白术等合而用,方如防己黄芪汤。慢性肾炎水肿、脾肾虚:常与党参、白术、茯苓同用。阳气虚弱:用于疮疡久不溃破而内陷,有促进溃破及局限作用。痈疽久不穿头,常与穿山甲、皂角刺、当归、川芎同用。疮疡溃破:久不收口,有生肌收口之作用,常配银花、皂刺、地丁等。脓液清洗,与党参、肉桂等同用。肺气虚证:咳喘日久,气短神疲,痰雍于肺无力咯出。常配伍紫菀、款冬等,温肺定喘,健肺气之品。脾生痰,肺储痰,所以健太阴以祛痰,黄芪补气所以尤善治气虚。气虚衰弱:倦怠乏力,或中气下陷、脱肛、子宫脱垂。补气健脾,常与党参、白术等配伍;用于益气升阳而举陷,常与党参、升麻、柴胡、炙甘草等合用。
丹参,用于胸痹心痛,脘腹胁痛,瘕瘕积聚,热痹疼痛,心烦不眠,月经不调,痛经经闭,疮疡肿痛。
茯苓,用于水肿尿少,痰饮眩悸,脾虚食少,便溏泄泻,心神不安,惊悸失眠。
陈皮,用于脘腹胀满,食少吐泻,咳嗽痰多。
苍术,用于湿阻中焦,脘腹胀满,泄泻,水肿,脚气痿蹙,风湿痹痛,风寒感冒,夜盲,眼目昏涩。
当归,补血;活血;调经止痛;润燥滑肠。主血虚诸证;月经不调;经闭;痛经;症瘕结聚;崩漏;虚寒腹痛;痿痹;肌肤麻木;肠燥便难;赤痢后重;痈疽疮疡;跌扑损伤。
川芎,行气开郁,法风燥湿,活血止痛。治风冷头痛旋晕,胁痛腹疼,寒痹筋挛,经闭,难产,产后瘀阻块痛,痈疽疮疡。用于月经不调,经闭痛经,瘕腹痛,胸胁刺痛,跌扑肿痛,头痛,风湿痹痛。
甘草,用于心气虚,心悸怔忡,脉结代,以及脾胃气虚,倦怠乏力等。前者,常与桂枝配伍,如桂枝甘草汤、炙甘草汤。后者,常与党参、白术等同用,如四君子汤、理中丸等。用于痈疽疮疡、咽喉肿痛等。可单用,内服或外敷,或配伍应用。痈疽疮疡,常与金银花、连翘等同用,共奏清热解毒之功,如仙方活命饮。咽喉肿痛,常与桔梗同用,如桔梗汤。若农药、食物中毒,常配绿豆或与防风水煎服。用于气喘咳嗽。可单用,亦可配伍其他药物应用。如治湿痰咳嗽的二陈汤;治寒痰咳喘的苓甘五味姜辛汤;治燥痰咳嗽的桑杏汤;治热毒而致肺痈咳唾腥臭脓痰的桔梗汤;治咳唾涎沫的甘草干姜汤等。另风热咳嗽、风寒咳嗽、热痰咳嗽亦常配伍应用。用于胃痛、腹痛及腓肠肌挛急疼痛等;用于调和某些药物的烈性。如调味承气汤用本品缓和大黄、芒硝的泻下作用及其对胃肠道的刺激。另外,在许多处方中也常用本品调和诸药。甘草有类似肾上腺皮质激素样作用。对组胺引起的胃酸分泌过多有抑制作用;并有抗酸和缓解胃肠平滑肌痉挛作用。甘草黄酮、甘草浸膏及甘草次酸均有明显的镇咳作用;祛痰作用也较显著,其作用强度为甘草酸>甘草黄酮>甘草浸膏。甘草还有抗炎,抗过敏作用,能保护发炎的咽喉和气管粘膜。甘草浸膏和甘草酸对某些毒物有类似葡萄糖醛酸的解毒作用。甘草常用来治疗随更年期而来的症状.因为甘草里含有甘草素,是一种类似激素的化合物,它有助于平衡女性体内的激素含量。甘草所含的次酸能阻断致癌物诱发肿瘤生长的作用。
本发明在临床观察过程中,102例患者均完成临床观察,无脱落退出病例。经过本发明药物治疗三个疗程的脾虚痰湿型PCOS患者,参照《中药新药临床研究指导原则》判定标准,治疗病例51例,显效33例,有效16例,无效2例,显效率64.7%,总有效率96.1%,观察组在显效率和总有效率方面临床效果更为显著;治疗后,患者T、LH、FSH血清内分泌激素水平均有下降,治疗前后LH/FSH、T值比较均有极其显著性差异(P<0.01)。
以上所述仅是对本发明的较佳实施例而已,并非对本发明作任何形式上的限制,凡是依据本发明的技术实质对以上实施例所做的任何简单修改,等同变化与修饰,均属于本发明技术方案的范围内。
Claims (10)
1.一种治疗脾虚痰湿型多囊卵巢综合征的药物组合物,其特征在于,所述治疗脾虚痰湿型多囊卵巢综合征的药物组合物由黄芪2g、丹参3g、茯苓2g、陈皮2g、苍术4g、当归3g、川芎1g和甘草1.5g组成。
2.一种如权利要求1所述治疗脾虚痰湿型多囊卵巢综合征的药物组合物的制备方法,其特征在于,所述治疗脾虚痰湿型多囊卵巢综合征的药物组合物的制备方法包括以下步骤:
步骤一,在制作时,取黄芪2g、丹参3g、茯苓2g、陈皮2g、苍术4g、当归3g、川芎1g和甘草1.5g,洗净后,加水进行煎煮,煎煮过后,收集煎煮出的提取液;
步骤二,随后重复煎煮,进行多次提纯,全部材料提纯完毕后,将最后的提取液进行混合,随后加入乙醇进行保存。
3.如权利要求2所述的治疗脾虚痰湿型多囊卵巢综合征的药物组合物的制备方法,其特征在于,所述步骤一中将提取液通过过滤精度为0.08μm介质过滤,以去除提取液III中的粒径大于0.08μm的大分子物质,再将滤出液通过超滤过滤来滤出提取液中无药效的分子量大于5000~10000道尔顿的有机大分子物质,得到纯度高的中药有效成份提取液;超滤过滤,所采用的超滤膜随处理中药不同选择切割分子量为5000~10000道尔顿;所述超滤过滤,可以根据所提取中药有效成份的分子量选取不同切割分子量的超滤膜。
4.如权利要求2所述的治疗脾虚痰湿型多囊卵巢综合征的药物组合物的制备方法,其特征在于,所述步骤一中中药有效成份进一步提纯、浓缩:将提取液通过纳滤膜以去除提取液IV中的有机溶剂水溶液的有机溶剂;所述的铀滤过滤,所采用的铀滤膜随有机溶剂水溶液中有机溶剂分子量的不同选择切割分子量为200~500道尔顿的纳滤膜。
5.如权利要求2所述的治疗脾虚痰湿型多囊卵巢综合征的药物组合物的制备方法,其特征在于,所述步骤一中将黄芪实体破啐成0.5~1厘米大碎块,投入不锈钢的提取锅中,加黄芪干重8倍的95%食用乙醇,78℃回流1小时,放出醇提液;残渣仍留在锅中,再加8倍重量的75%食用乙醇,78℃回流1小时,放出乙醇提取液;残渣仍留在锅中,再加8倍量50%食用乙醇,78℃回流1小时,放出乙醇提取液;将3次醇提液合并,在贮液槽中静置10小时,取出上层清液,弃去底部沉淀物;上清液回收乙醇。
6.一种由权利要求1所述治疗脾虚痰湿型多囊卵巢综合征的药物组合物制备的片剂。
7.一种由权利要求1所述治疗脾虚痰湿型多囊卵巢综合征的药物组合物制备的薄膜衣片剂。
8.一种由权利要求1所述治疗脾虚痰湿型多囊卵巢综合征的药物组合物制备的肠溶衣片剂。
9.一种由权利要求1所述治疗脾虚痰湿型多囊卵巢综合征的药物组合物制备的胶囊剂。
10.一种由权利要求1所述治疗脾虚痰湿型多囊卵巢综合征的药物组合物制备的口服液。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810754444.2A CN108653434A (zh) | 2018-07-11 | 2018-07-11 | 一种治疗脾虚痰湿型多囊卵巢综合征的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810754444.2A CN108653434A (zh) | 2018-07-11 | 2018-07-11 | 一种治疗脾虚痰湿型多囊卵巢综合征的药物组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108653434A true CN108653434A (zh) | 2018-10-16 |
Family
ID=63772613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810754444.2A Pending CN108653434A (zh) | 2018-07-11 | 2018-07-11 | 一种治疗脾虚痰湿型多囊卵巢综合征的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108653434A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109224054A (zh) * | 2018-11-28 | 2019-01-18 | 辽宁中医药大学 | 一种用于肥胖型pcos穴位贴敷的中药组合物及其制备方法 |
CN111317777A (zh) * | 2020-05-08 | 2020-06-23 | 河南中医药大学 | 一种治疗肾虚痰湿型多囊卵巢综合征不孕症的中药汤 |
CN116036162A (zh) * | 2023-01-17 | 2023-05-02 | 上海中医药大学附属岳阳中西医结合医院 | 一种治疗多囊卵巢综合征的中药组合物及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102145041A (zh) * | 2010-02-09 | 2011-08-10 | 侯凤祥 | 一种具有治疗多囊卵巢综合症作用的药物组合物 |
CN104147551A (zh) * | 2014-09-02 | 2014-11-19 | 马俊安 | 一种治疗多囊卵巢综合征的中药 |
CN105596495A (zh) * | 2016-01-06 | 2016-05-25 | 侯丽辉 | 治疗青春期多囊卵巢综合征的中药复方 |
-
2018
- 2018-07-11 CN CN201810754444.2A patent/CN108653434A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102145041A (zh) * | 2010-02-09 | 2011-08-10 | 侯凤祥 | 一种具有治疗多囊卵巢综合症作用的药物组合物 |
CN104147551A (zh) * | 2014-09-02 | 2014-11-19 | 马俊安 | 一种治疗多囊卵巢综合征的中药 |
CN105596495A (zh) * | 2016-01-06 | 2016-05-25 | 侯丽辉 | 治疗青春期多囊卵巢综合征的中药复方 |
Non-Patent Citations (4)
Title |
---|
何红: "帅焘老师治疗多囊卵巢综合症的临证经验", 《云南中医中药杂志》 * |
宋诗思;等: "浅析治疗多囊卵巢综合征治疗经验", 《大众科技》 * |
崔红花;等: "正交试验优化黄芪的乙醇提取工艺", 《中草药》 * |
王晨晔;等: "苍附导痰汤加减联合针刺对肥胖型多囊卵巢综合征患者糖脂代谢及排卵率的影响", 《现代中西医结合杂志》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109224054A (zh) * | 2018-11-28 | 2019-01-18 | 辽宁中医药大学 | 一种用于肥胖型pcos穴位贴敷的中药组合物及其制备方法 |
CN109224054B (zh) * | 2018-11-28 | 2021-08-13 | 辽宁中医药大学 | 一种用于肥胖型pcos穴位贴敷的中药组合物及其制备方法 |
CN111317777A (zh) * | 2020-05-08 | 2020-06-23 | 河南中医药大学 | 一种治疗肾虚痰湿型多囊卵巢综合征不孕症的中药汤 |
CN116036162A (zh) * | 2023-01-17 | 2023-05-02 | 上海中医药大学附属岳阳中西医结合医院 | 一种治疗多囊卵巢综合征的中药组合物及其应用 |
CN116036162B (zh) * | 2023-01-17 | 2023-11-21 | 上海中医药大学附属岳阳中西医结合医院 | 一种治疗多囊卵巢综合征的中药组合物及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1330347C (zh) | 中药滋补膏 | |
CN101422579B (zh) | 一种治疗口腔溃疡的中药制剂 | |
CN108653434A (zh) | 一种治疗脾虚痰湿型多囊卵巢综合征的药物组合物 | |
CN104306766B (zh) | 防治放射性口腔黏膜炎的中药方剂及其制作方法 | |
CN1048175C (zh) | 一种调节女性性机能的口服液 | |
CN103330826A (zh) | 一种治疗肺阴虚的中药组合物 | |
CN102048831A (zh) | 一种治疗肝硬化的中药 | |
CN104940596A (zh) | 一种治疗糖尿病肾病的中药组合物及其制备方法 | |
CN105055841A (zh) | 一种治疗慢性咽炎的药物及其制备方法 | |
CN104887747A (zh) | 一种治疗脑血栓的中药组合物及其制备方法 | |
CN104353029A (zh) | 一种润肺橘红膏及其制备方法 | |
CN105902827A (zh) | 提高人体免疫力的中药组合物及其制备方法 | |
CN104984296A (zh) | 一种治疗女性更年期综合症的药物组合物及其制备方法 | |
CN105999058B (zh) | 鬼针草降脂片 | |
CN104258359A (zh) | 一种用于治疗妊娠反应的中药组合物及其制剂的制备方法 | |
CN102172369A (zh) | 一种治疗肝硬化的中药 | |
CN101485823B (zh) | 一种用于治疗肺癌的药物及其制备方法 | |
CN105250968A (zh) | 一种治疗哮喘的中药制剂 | |
CN106074912B (zh) | 一种治疗心脑血管疾病的中药制剂 | |
CN104887950A (zh) | 一种治疗乳痈的中药组合物 | |
CN104306847A (zh) | 一种六味补气胶囊及其制备工艺 | |
CN102166303B (zh) | 一种治疗慢性萎缩性胃炎的中药组合物 | |
CN102139009A (zh) | 一种治疗慢性前列腺炎的中药 | |
CN102379965A (zh) | 一种治疗慢性前列腺炎的中药 | |
CN101530479B (zh) | 一种治疗糖尿病并发肌肉萎缩的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Chang Hui Inventor after: Jia Liyan Inventor before: Jia Liyan Inventor before: Chang Hui |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181016 |